Učitavanje...
VEGFR-TKIs combined with chemotherapy for advanced non-small cell lung cancer: A systematic review
Introduction: To estimate the efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in combination with chemotherapy for patients with advanced non-small cell lung cancer (NSCLC). Methods: We searched PubMed, PMC database, EMBASE, EBSCO-Medline, C...
Spremljeno u:
| Izdano u: | J Cancer |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ivyspring International Publisher
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400799/ https://ncbi.nlm.nih.gov/pubmed/30854085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29643 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|